Evidence map›Paper›PMID 30297802›Full record

ArticleScientific reports2018

Metallo-Curcumin-Conjugated DNA Complexes Induces Preferential Prostate Cancer Cells Cytotoxicity and Pause Growth of Bacterial Cells.

Srivithya Vellampatti, Gopalakrishnan Chandrasekaran, Sekhar Babu Mitta, Vinoth-Kumar Lakshmanan, Sung Ha Park

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Veterinary world · 2025
    Article
  5. Article
  6. Article
  7. ACS omega · 2021
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. A Review of Curcumin and Its Derivatives as Anticancer Agents.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Srivithya VellampattiSungkyunkwan Advanced Institute of Nanotechnology (SAINT) and Department of Physics, Sungkyunkwan University, Suwon, 16419, Korea.ORCID http://orcid.org/0000-0003-0020-5711
Gopalakrishnan ChandrasekaranDepartment of Biomedical Sciences, Chonnam National University Medical School, Gwangju, 61469, Korea.
Sekhar Babu MittaSungkyunkwan Advanced Institute of Nanotechnology (SAINT) and Department of Physics, Sungkyunkwan University, Suwon, 16419, Korea.ORCID http://orcid.org/0000-0002-8011-5291
Vinoth-Kumar LakshmananDepartment of Biomedical Sciences, Chonnam National University Medical School, Gwangju, 61469, Korea. lvinothkumarbme@siet.ac.in.
Sung Ha ParkSungkyunkwan Advanced Institute of Nanotechnology (SAINT) and Department of Physics, Sungkyunkwan University, Suwon, 16419, Korea. sunghapark@skku.edu.ORCID http://orcid.org/0000-0002-0256-3363

Funding

National Research Foundation of Korea (NRF) 2018R1A2B6008094
6 · The paper itself

Abstract

DNA nanotechnology can be used to create intricate DNA structures due to the ability to direct the molecular assembly of nanostructures through a bottom-up approach. Here, we propose nanocarriers composed of both synthetic and natural DNA for drug delivery. The topological, optical characteristics, and interaction studies of Cu

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsBacillus subtilisCell Line, TumorCell SurvivalCoordination ComplexesCurcuminDNAEscherichia coliEscherichia coli InfectionsHumansMaleMetalsModels, MolecularNanoconjugatesProstatic NeoplasmsAnti-Bacterial AgentsAntineoplastic AgentsCoordination ComplexesCurcuminDNAMetalsNanoconjugates

Identifiers

PMID30297802
PMCPMC6175843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.